Ganesan Senthil Kumar (Senthil Kumar Ganesan)

Years Active: 2019-2021
Publications (10 Years): 5

Indian Institute of Chemical Biology CSIR

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Indian Institute of Chemical Biology CSIR Nov 18 2016

India

Scientist :: Translational Research Unit of Excellence

Publications

Nalini Devarajan, Selvaraj Jayaraman, Jaideep Mahendra, Purushothaman Venkatratnam, Ponnulakshmi Rajagopal, Hema Palaniappan, Ganesan Senthil Kumar
Berberine-A potent chemosensitizer and chemoprotector to conventional cancer therapies. Phytotherapy research : PTR 35 (6) (2021)
Jayaraman Selvaraj, Nalini Devarajan, Ponnulakshmi Rajagopal, Shyamaladevi Babu, Ganesan Senthil Kumar, Vishnu Priya Veeraraghavan, Chella Perumal Palanisamy, Bo Cui, Vijayalakshmi Periyasamy, Kirubhanand Chandrasekar
β-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKKβ/NF-κB and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats. Molecules (Basel, Switzerland) 26 (7) (2021)
Ganesan Senthil Kumar, Purushothaman Venkatratnam, Jaideep Mahendra, Nalini Devarajan
Increased mortality of COVID-19 infected diabetes patients: role of furin proteases. International journal of obesity (2005) 44 (12) (2020)
Devarajan Nalini, Jayaraman Selvaraj, Ganesan Senthil Kumar
Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia. Journal of cancer research and clinical oncology 146 (1) (2019)
Nidhi Kumari, Aditi Karmakar, Ganesan Senthil Kumar
Targeting epigenetic modifications as a potential therapeutic option for diabetic retinopathy. Journal of cellular physiology 235 (3) (2019)

Ganesan Senthil Kumar.css-eqlu8i{font-size:small;padding-left:4px;} (Senthil Kumar Ganesan)